نتائج البحث - "Simone M. Goldinger"

51

Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma

المساهمون: University of Zurich, Zimmer, Lisa

المصدر: European journal of cancer (Oxford, England : 1990). 75

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Programmed Cell Death 1 Receptor, Medizin, 610 Medicine & health, Ipilimumab, Pembrolizumab, Kaplan-Meier Estimate, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Medicine, Humans, 1306 Cancer Research, Melanoma, Advanced melanoma, Aged, Retrospective Studies, Aged, 80 and over, business.industry, Anti pd 1, 10177 Dermatology Clinic, Antibodies, Monoclonal, Retrospective cohort study, Middle Aged, medicine.disease, Surgery, 030104 developmental biology, Nivolumab, Treatment Outcome, 030220 oncology & carcinogenesis, Disease Progression, 2730 Oncology, Female, business, Progressive disease, medicine.drug

وصف الملف: Publikation_Goldinger.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b2bf6eab2d21cf7deeefc52fb9bc7b3Test
https://pubmed.ncbi.nlm.nih.gov/28214657Test

52

Developments in targeted therapy in melanoma

المؤلفون: R. Pitocco, J. Mangana, N. Bentele-Jaberg, Simone M. Goldinger, Egle Ramelyte, Valerie C Amann, S. Thurneysen, Reinhard Dummer

المساهمون: University of Zurich, Dummer, R

وصف الملف: 671_Amman V. et al._Developments in targeted therapy in melanoma_EJSO 2016.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b655f78266058f3f432dffb88ba360dTest
https://doi.org/10.5167/uzh-128596Test

53

Critical aspects to achieve a high-quality melanoma clinic

المؤلفون: Simone M. Goldinger, Egle Ramelyte, Ralph P. Braun, Mitch Levesque, Reinhard Dummer

المصدر: Current opinion in oncology. 29(2)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c00e88118643c9c91acecae7cd1b9643Test
https://pubmed.ncbi.nlm.nih.gov/28027104Test

54

Case Report: Encephalitis, with Brainstem Involvement, Following Checkpoint Inhibitor Therapy in Metastatic Melanoma

المؤلفون: Daniela Mihic-Probst, Henning Leske, Selina Thurneysen, Elisabeth J. Rushing, Simone M. Goldinger, J. Mangana, Simon Bossart, Hannes W. Nagel, Karl Frontzek, Reinhard Dummer

المساهمون: University of Zurich, Dummer, Reinhard

المصدر: The oncologist. 22(6)

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, 10208 Institute of Neuropathology, Ipilimumab, 610 Medicine & health, Pembrolizumab, Disease, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, 10049 Institute of Pathology and Molecular Pathology, Health care, medicine, otorhinolaryngologic diseases, Humans, 1306 Cancer Research, Adverse effect, neoplasms, Melanoma, business.industry, 10177 Dermatology Clinic, Antibodies, Monoclonal, Immunotherapy, 10181 Clinic for Nuclear Medicine, Middle Aged, medicine.disease, 030220 oncology & carcinogenesis, Immunology, Encephalitis, 2730 Oncology, Female, business, Brief Communications, 030217 neurology & neurosurgery, medicine.drug, Brain Stem

وصف الملف: 692_Bossart_S._et_al._Encephalitis,_with_Brainstem_Involvement,_Following_Checkpoint_The_Oncologist_2017.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2385c16d3d9e235718ea00f2470ba6a6Test
https://pubmed.ncbi.nlm.nih.gov/28559410Test

55

Pembrolizumab-triggered Uveitis: An Additional Surrogate Marker for Responders in Melanoma Immunotherapy?

المؤلفون: Samia Abed Maillard, Lukas Flatz, Daniel E. Speiser, Reinhard Rüesch, Fabienne Keller, Stefan Diem, Simone M. Goldinger, Ursula Urner-Bloch, Reinhard Dummer, Marco Siano

المساهمون: University of Zurich, Flatz, Lukas

المصدر: Journal of Immunotherapy

مصطلحات موضوعية: Oncology, Male, Cancer Research, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Immunology, Programmed Cell Death 1 Receptor, 610 Medicine & health, Ipilimumab, Autoimmunity, Pembrolizumab, Antibodies, Monoclonal, Humanized, Uveitis, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Immunology and Allergy, Humans, 1306 Cancer Research, CTLA-4 Antigen, Colitis, Melanoma, Aged, Pharmacology, 2403 Immunology, Surrogate endpoint, business.industry, 10177 Dermatology Clinic, Immunotherapy, Middle Aged, medicine.disease, 3. Good health, 3004 Pharmacology, Treatment Outcome, 030220 oncology & carcinogenesis, Monoclonal, 2723 Immunology and Allergy, 030221 ophthalmology & optometry, Neoplasms, Unknown Primary, business, medicine.drug

وصف الملف: 667_Diem S. et al._Pembrolizumab-trigged Uveitis_Immunotherapy 2016.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1463f1e7d3676f85f258311a918183d6Test
https://pubmed.ncbi.nlm.nih.gov/27662340Test

56

Targeted therapy in melanoma – the role of BRAF, RAS and KIT mutations

المؤلفون: Carla Murer, Pascale Stieger, Simone M. Goldinger, Reinhard Dummer

المصدر: EJC Supplements

مصطلحات موضوعية: Trametinib, Cancer Research, business.industry, Kinase, Melanoma, medicine.medical_treatment, MEK inhibitor, Dabrafenib, Imatinib, medicine.disease, Bioinformatics, Article, Targeted therapy, Oncology, medicine, Cancer research, Vemurafenib, business, neoplasms, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b4d2a58c79d9335831bd10f99ca96a8Test

57

Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8+T-cell responses in melanoma patients

المؤلفون: Petra Baumgaertner, Reinhard Dummer, Simone M. Goldinger, Katrin Schwarz, Olivier Michielin, Anya Hammann-Haenni, John O. Prior, Joerg Willers, Daniela Mihic-Probst, Christine Geldhof, Daniel E. Speiser, Martin F. Bachmann, Thomas M. Kündig

المصدر: European Journal of Immunology. 42:3049-3061

مصطلحات موضوعية: business.industry, medicine.medical_treatment, Melanoma, Immunology, Imiquimod, medicine.disease, Vaccination, Immunology and Allergy, Medicine, Cytotoxic T cell, Lymph, business, Interleukin-7 receptor, Adjuvant, CD8, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::60d2eb6db61097a521e8ff7fb4cb89b5Test
https://doi.org/10.1002/eji.201142361Test

58

MEK inhibitor-associated retinopathy (MEKAR) in metastatic melanoma: Long-term ophthalmic effects

المؤلفون: Ursula Urner-Bloch, Martin Urner, Nicoletta F Jaberg-Bentele, Anna L. Frauchiger, Simone M. Goldinger, Reinhard Dummer

المصدر: European journal of cancer (Oxford, England : 1990). 65

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3feb9dc5459aeebe0629ebcba52b4513Test
https://pubmed.ncbi.nlm.nih.gov/27497344Test

59

An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxel

المؤلفون: Michael Kunz, Phil F. Cheng, Emmanuella Guenova, S. Thurneysen, Reinhard Dummer, Simone M. Goldinger, Mirjam Nägeli, M. Ziegler, J. Mangana, Nicoletta F Jaberg-Bentele, Hannes W. Nagel, Mitch Levesque

المصدر: The British journal of dermatology. 175(5)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, medicine.medical_specialty, Indazoles, Skin Neoplasms, Paclitaxel, medicine.drug_class, medicine.medical_treatment, Administration, Oral, Dermatology, Pharmacology, Tyrosine-kinase inhibitor, Drug Administration Schedule, Pazopanib, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, CXCL13, Infusions, Intravenous, Melanoma, Sulfonamides, medicine.diagnostic_test, business.industry, medicine.disease, 3. Good health, Up-Regulation, CXCL1, 030104 developmental biology, Cytokine, Pyrimidines, Treatment Outcome, chemistry, 030220 oncology & carcinogenesis, Skin biopsy, Cytokines, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87069b105088f39a96cedaa42343db17Test
https://pubmed.ncbi.nlm.nih.gov/27168024Test

60

Cytotoxic cutaneous adverse drug reactions during anti-PD-1 therapy

المؤلفون: Pascale Stieger, Lars E. French, Emmanuel Contassot, Barbara Meier, Simone M. Goldinger, Sara Micaletto, Reinhard Dummer

المساهمون: University of Zurich, Dummer, Reinhard

مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Biopsy, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Antineoplastic Agents, 610 Medicine & health, Vitiligo, Skin Diseases, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, 1306 Cancer Research, Neoplasm Metastasis, Neoplasm Staging, Clinical Trials as Topic, integumentary system, medicine.diagnostic_test, business.industry, Gene Expression Profiling, Melanoma, Cancer, 10177 Dermatology Clinic, Immunotherapy, medicine.disease, Immunohistochemistry, Dermatology, Rash, Toxic epidermal necrolysis, Drug eruption, Oncology, 030220 oncology & carcinogenesis, Female, 2730 Oncology, medicine.symptom, business

وصف الملف: 646_Goldinger SM et al._Cytotoxic cutaneous adverse drug reactions during anti-PD-1 therapy_Clincanres 2016.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::545930d7b68599e5501acf2ca9e7d345Test
https://doi.org/10.5167/uzh-123666Test

تنقيح النتائج